The Sackler Family’s Plan Is Nixed By Ejusdem Generis In Purdue Pharma

Discusses the opinion of the U.S. Supreme Court in Harrington v. Purdue Pharma, L.P., 603 S.Ct. ____ (June 27, 2024), and future possibilities for that litigation.